Abstract: A system for removing charged particles from the brain in which a cannula with a distal anode, a proximal cathode and a vacuum are used. The cannula also comprises a fluid delivery port that is functionally connected to a vacuum, and holes with the distal end of the cannula. The charged species in the brain tissue are drawn to the anode that is on the distal end of the probe, when a cathode is placed on the skull of the patient and an appropriate electric field is applied between the anode and cathode. The use of a vacuum within the device to remove the destructive charged particles.
Abstract: Novel molecules based upon hybridization of curcumin and hydroxystilbenes, such as resveratrol. It is believed that these novel molecules will have special application in treating Alzheimer's Disease.
Abstract: A method of treating a fractured vertebral body by using a) a plurality of reinforcement rods combined with the b) a bone growth agent, wherein the reinforcement rods act to mechanically join disparate bone fragments across the fracture planes, thereby stabilizing the fracture site, and the bone growth agent promotes the growth of new bone across the fracture planes, thereby permanently replacing the fracture site with new bone.
Abstract: An interspinous spacer having opposed, pivotally connected s-shaped members that can enter the interspinous space in an initial state and then rotate to a final state to secure the implant to the adjacent interspinous processes.
December 22, 2005
Date of Patent:
September 8, 2009
DePuy Spine, Inc.
Seungkyu Daniel Kwak, John Riley Hawkins
Abstract: A banana shaped intevertebral fusion cage having a domed profile, an internal planar wall defining first and second graft chambers, asymmetrically disposed leading and trailing insertion, and an anterior wall recess.
December 31, 2002
Date of Patent:
March 10, 2009
Depuy Acromed, Inc.
Charles M. Bartish, Jr., Douglas Scott Bireley, Bradley Thomas Moore
Abstract: This invention relates to a method and compositions for treating pathological intervertebral discs comprising the step of delivering an agent that causes chemical crosslinking of the native molecular components of the disc. Supplemental materials which are susceptible to crosslinking by the aforementioned agent are optionally delivered to the disc in order to increase and maintain disc height.